Colorectal cancer (CRC) is known to be the third leading cause of cancer death in both men and women throughout the world (1). In developed countries, CRC is the third most common malignancy. Unfortunately, routine colon cancer therapies such as surgery, radiation-based therapy, chemotherapy, and targeted therapy are not able to cure this disease. However, the discovery of new interventions for the treatment of colon cancer with low side effects are ongoing (2). Bio-toxins, which are produced by many insects as a defense against predators, are known to have both pharmacological as well as toxicological effects (3, 4, 5). Apitoxin, also known as bee venom (BV), is a natural product that has been used for treating rheumatoid arthritis, multiple sclerosis, and many other diseases (6, 7). Bee